NL2008038C2 - Activated or biologically functionalised polymer network. - Google Patents
Activated or biologically functionalised polymer network. Download PDFInfo
- Publication number
- NL2008038C2 NL2008038C2 NL2008038A NL2008038A NL2008038C2 NL 2008038 C2 NL2008038 C2 NL 2008038C2 NL 2008038 A NL2008038 A NL 2008038A NL 2008038 A NL2008038 A NL 2008038A NL 2008038 C2 NL2008038 C2 NL 2008038C2
- Authority
- NL
- Netherlands
- Prior art keywords
- polymer network
- segment
- porous polymer
- groups
- optionally substituted
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title claims description 225
- -1 polyetheresters Polymers 0.000 claims description 33
- 229920000728 polyester Polymers 0.000 claims description 28
- 229920000570 polyether Polymers 0.000 claims description 26
- 210000001519 tissue Anatomy 0.000 claims description 26
- 150000001875 compounds Chemical class 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 23
- 229920002732 Polyanhydride Polymers 0.000 claims description 22
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical group CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims description 19
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 18
- 229920000669 heparin Polymers 0.000 claims description 18
- 229960002897 heparin Drugs 0.000 claims description 18
- 229920000515 polycarbonate Polymers 0.000 claims description 18
- 239000004417 polycarbonate Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 17
- 125000003277 amino group Chemical group 0.000 claims description 16
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical group NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 15
- 239000004202 carbamide Chemical group 0.000 claims description 15
- 229910052757 nitrogen Inorganic materials 0.000 claims description 15
- 150000001408 amides Chemical group 0.000 claims description 14
- 150000004985 diamines Chemical class 0.000 claims description 14
- 125000002947 alkylene group Chemical group 0.000 claims description 13
- 239000002202 Polyethylene glycol Substances 0.000 claims description 12
- 150000008064 anhydrides Chemical group 0.000 claims description 12
- 150000002148 esters Chemical class 0.000 claims description 12
- 229910052698 phosphorus Inorganic materials 0.000 claims description 12
- 229920001223 polyethylene glycol Polymers 0.000 claims description 12
- 229910052717 sulfur Inorganic materials 0.000 claims description 12
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 229920002988 biodegradable polymer Polymers 0.000 claims description 10
- 229910052760 oxygen Inorganic materials 0.000 claims description 10
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 9
- 229920003232 aliphatic polyester Polymers 0.000 claims description 9
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 8
- 239000004621 biodegradable polymer Substances 0.000 claims description 8
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 7
- 125000003107 substituted aryl group Chemical group 0.000 claims description 7
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000003102 growth factor Substances 0.000 claims description 6
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims description 6
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 239000007822 coupling agent Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- JYVLIDXNZAXMDK-UHFFFAOYSA-N pentan-2-ol Chemical compound CCCC(C)O JYVLIDXNZAXMDK-UHFFFAOYSA-N 0.000 claims description 4
- AQIXEPGDORPWBJ-UHFFFAOYSA-N pentan-3-ol Chemical compound CCC(O)CC AQIXEPGDORPWBJ-UHFFFAOYSA-N 0.000 claims description 4
- 229920001184 polypeptide Polymers 0.000 claims description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 3
- 108010035532 Collagen Proteins 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- 125000006702 (C1-C18) alkyl group Chemical group 0.000 claims description 2
- 102000009027 Albumins Human genes 0.000 claims description 2
- 108010088751 Albumins Proteins 0.000 claims description 2
- 102000016942 Elastin Human genes 0.000 claims description 2
- 108010014258 Elastin Proteins 0.000 claims description 2
- 102000009123 Fibrin Human genes 0.000 claims description 2
- 108010073385 Fibrin Proteins 0.000 claims description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 2
- 229940050528 albumin Drugs 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 235000014633 carbohydrates Nutrition 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 229960005188 collagen Drugs 0.000 claims description 2
- 210000002808 connective tissue Anatomy 0.000 claims description 2
- KTHXBEHDVMTNOH-UHFFFAOYSA-N cyclobutanol Chemical compound OC1CCC1 KTHXBEHDVMTNOH-UHFFFAOYSA-N 0.000 claims description 2
- XCIXKGXIYUWCLL-UHFFFAOYSA-N cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 claims description 2
- 229920002549 elastin Polymers 0.000 claims description 2
- 229950003499 fibrin Drugs 0.000 claims description 2
- 229940088597 hormone Drugs 0.000 claims description 2
- 239000005556 hormone Substances 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- ISCMYZGMRHODRP-UHFFFAOYSA-N 3-(iminomethylideneamino)-n,n-dimethylpropan-1-amine Chemical compound CN(C)CCCN=C=N ISCMYZGMRHODRP-UHFFFAOYSA-N 0.000 claims 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- UACSZOWTRIJIFU-UHFFFAOYSA-N hydroxymethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCO UACSZOWTRIJIFU-UHFFFAOYSA-N 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 239000000463 material Substances 0.000 description 21
- 229920002635 polyurethane Polymers 0.000 description 21
- 239000004814 polyurethane Substances 0.000 description 21
- 238000007098 aminolysis reaction Methods 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 229920001577 copolymer Polymers 0.000 description 10
- 230000007704 transition Effects 0.000 description 9
- 230000015556 catabolic process Effects 0.000 description 8
- 238000006731 degradation reaction Methods 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 229920001477 hydrophilic polymer Polymers 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 125000001931 aliphatic group Chemical group 0.000 description 6
- 230000036760 body temperature Effects 0.000 description 6
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 6
- 230000009477 glass transition Effects 0.000 description 6
- 125000005442 diisocyanate group Chemical group 0.000 description 5
- 125000000524 functional group Chemical group 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 239000000919 ceramic Substances 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 238000005191 phase separation Methods 0.000 description 4
- 229920001059 synthetic polymer Polymers 0.000 description 4
- OVBFMUAFNIIQAL-UHFFFAOYSA-N 1,4-diisocyanatobutane Chemical compound O=C=NCCCCN=C=O OVBFMUAFNIIQAL-UHFFFAOYSA-N 0.000 description 3
- 239000007987 MES buffer Substances 0.000 description 3
- 229920001730 Moisture cure polyurethane Polymers 0.000 description 3
- 229920000954 Polyglycolide Polymers 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229920001400 block copolymer Polymers 0.000 description 3
- 125000001033 ether group Chemical group 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 3
- 230000005499 meniscus Effects 0.000 description 3
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 229920001610 polycaprolactone Polymers 0.000 description 3
- 239000004632 polycaprolactone Substances 0.000 description 3
- 229920006254 polymer film Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 238000006065 biodegradation reaction Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 238000003125 immunofluorescent labeling Methods 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 229920001693 poly(ether-ester) Polymers 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920001748 polybutylene Polymers 0.000 description 2
- 239000004633 polyglycolic acid Substances 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
- FDYWJVHETVDSRA-UHFFFAOYSA-N 1,1-diisocyanatobutane Chemical compound CCCC(N=C=O)N=C=O FDYWJVHETVDSRA-UHFFFAOYSA-N 0.000 description 1
- VKSWWACDZPRJAP-UHFFFAOYSA-N 1,3-dioxepan-2-one Chemical compound O=C1OCCCCO1 VKSWWACDZPRJAP-UHFFFAOYSA-N 0.000 description 1
- VPVXHAANQNHFSF-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1 VPVXHAANQNHFSF-UHFFFAOYSA-N 0.000 description 1
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
- PWGJDPKCLMLPJW-UHFFFAOYSA-N 1,8-diaminooctane Chemical compound NCCCCCCCCN PWGJDPKCLMLPJW-UHFFFAOYSA-N 0.000 description 1
- JCUZDQXWVYNXHD-UHFFFAOYSA-N 2,2,4-trimethylhexane-1,6-diamine Chemical compound NCCC(C)CC(C)(C)CN JCUZDQXWVYNXHD-UHFFFAOYSA-N 0.000 description 1
- DPQHRXRAZHNGRU-UHFFFAOYSA-N 2,4,4-trimethylhexane-1,6-diamine Chemical compound NCC(C)CC(C)(C)CCN DPQHRXRAZHNGRU-UHFFFAOYSA-N 0.000 description 1
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 1
- NDXNCTAJOQSKIO-UHFFFAOYSA-N 2-butyl-2-ethylpentane-1,5-diamine Chemical compound CCCCC(CC)(CN)CCCN NDXNCTAJOQSKIO-UHFFFAOYSA-N 0.000 description 1
- GAGWMWLBYJPFDD-UHFFFAOYSA-N 2-methyloctane-1,8-diamine Chemical compound NCC(C)CCCCCCN GAGWMWLBYJPFDD-UHFFFAOYSA-N 0.000 description 1
- JZUHIOJYCPIVLQ-UHFFFAOYSA-N 2-methylpentane-1,5-diamine Chemical compound NCC(C)CCCN JZUHIOJYCPIVLQ-UHFFFAOYSA-N 0.000 description 1
- RNLHGQLZWXBQNY-UHFFFAOYSA-N 3-(aminomethyl)-3,5,5-trimethylcyclohexan-1-amine Chemical compound CC1(C)CC(N)CC(C)(CN)C1 RNLHGQLZWXBQNY-UHFFFAOYSA-N 0.000 description 1
- LTZQJVGOFCCDQA-UHFFFAOYSA-N 3-methylhexane-1,6-diamine Chemical compound NCCC(C)CCCN LTZQJVGOFCCDQA-UHFFFAOYSA-N 0.000 description 1
- DZIHTWJGPDVSGE-UHFFFAOYSA-N 4-[(4-aminocyclohexyl)methyl]cyclohexan-1-amine Chemical compound C1CC(N)CCC1CC1CCC(N)CC1 DZIHTWJGPDVSGE-UHFFFAOYSA-N 0.000 description 1
- MBRGOFWKNLPACT-UHFFFAOYSA-N 5-methylnonane-1,9-diamine Chemical compound NCCCCC(C)CCCCN MBRGOFWKNLPACT-UHFFFAOYSA-N 0.000 description 1
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 229920001244 Poly(D,L-lactide) Polymers 0.000 description 1
- 229920001273 Polyhydroxy acid Polymers 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920001963 Synthetic biodegradable polymer Polymers 0.000 description 1
- FDLQZKYLHJJBHD-UHFFFAOYSA-N [3-(aminomethyl)phenyl]methanamine Chemical compound NCC1=CC=CC(CN)=C1 FDLQZKYLHJJBHD-UHFFFAOYSA-N 0.000 description 1
- ABPUBUORTRHHDZ-UHFFFAOYSA-N [4-(aminomethyl)-3-bicyclo[2.2.1]heptanyl]methanamine Chemical compound C1CC2(CN)C(CN)CC1C2 ABPUBUORTRHHDZ-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 125000005587 carbonate group Chemical group 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- YMHQVDAATAEZLO-UHFFFAOYSA-N cyclohexane-1,1-diamine Chemical compound NC1(N)CCCCC1 YMHQVDAATAEZLO-UHFFFAOYSA-N 0.000 description 1
- YQLZOAVZWJBZSY-UHFFFAOYSA-N decane-1,10-diamine Chemical compound NCCCCCCCCCCN YQLZOAVZWJBZSY-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- RAABOESOVLLHRU-UHFFFAOYSA-N diazene Chemical compound N=N RAABOESOVLLHRU-UHFFFAOYSA-N 0.000 description 1
- 229910000071 diazene Inorganic materials 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- QFTYSVGGYOXFRQ-UHFFFAOYSA-N dodecane-1,12-diamine Chemical compound NCCCCCCCCCCCCN QFTYSVGGYOXFRQ-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007247 enzymatic mechanism Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- ATJCASULPHYKHT-UHFFFAOYSA-N hexadecane-1,16-diamine Chemical compound NCCCCCCCCCCCCCCCCN ATJCASULPHYKHT-UHFFFAOYSA-N 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- SXJVFQLYZSNZBT-UHFFFAOYSA-N nonane-1,9-diamine Chemical compound NCCCCCCCCCN SXJVFQLYZSNZBT-UHFFFAOYSA-N 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- CJYCVQJRVSAFKB-UHFFFAOYSA-N octadecane-1,18-diamine Chemical compound NCCCCCCCCCCCCCCCCCCN CJYCVQJRVSAFKB-UHFFFAOYSA-N 0.000 description 1
- 150000002905 orthoesters Chemical class 0.000 description 1
- 230000000278 osteoconductive effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
- 229920002627 poly(phosphazenes) Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 239000000622 polydioxanone Substances 0.000 description 1
- 229920006149 polyester-amide block copolymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229920006264 polyurethane film Polymers 0.000 description 1
- 229920003226 polyurethane urea Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- AOHJOMMDDJHIJH-UHFFFAOYSA-N propylenediamine Chemical compound CC(N)CN AOHJOMMDDJHIJH-UHFFFAOYSA-N 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- MSVPBWBOFXVAJF-UHFFFAOYSA-N tetradecane-1,14-diamine Chemical compound NCCCCCCCCCCCCCCN MSVPBWBOFXVAJF-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- UFLMQSIBJOVDPA-UHFFFAOYSA-N tridecane-1,11-diamine Chemical compound CCC(N)CCCCCCCCCCN UFLMQSIBJOVDPA-UHFFFAOYSA-N 0.000 description 1
- BPSKTAWBYDTMAN-UHFFFAOYSA-N tridecane-1,13-diamine Chemical compound NCCCCCCCCCCCCCN BPSKTAWBYDTMAN-UHFFFAOYSA-N 0.000 description 1
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials For Medical Uses (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
Description
P96906NL00
Title: Activated or biologically functionalised polymer network
The invention is directed to a biodegradable porous polymer network, to a process for preparing a biodegradable porous polymer network, and to the use of a biodegradable polymer network. More in particular, the biodegradable porous polymer network of the invention may be activated, or 5 functionalised with a biological compound.
Tissue engineering is a multidisciplinary field which involves the application of the principles and methods of engineering and life sciences towards the fundamental understanding of structure-function relationships in normal and pathological mammalian tissues and the development of biological 10 substitutes that restore, maintain, or improve tissue function. The goal of tissue engineering is to surpass the limitations of conventional treatments based on organ transplantation and biomaterial implantation. It has the potential to produce a supply of immunologically tolerant ‘artificial’ organ and tissue substitutes that can grow with the patient. This should lead to a 15 permanent solution to the damaged organ or tissue without the need for supplementary therapies, thus making it a cost-effective treatment in the long term. As an example, a scaffold for replacing damaged meniscus tissue can be mentioned. Such a scaffold could guide new tissue ingrowth into the lost meniscus and accordingly meniscus regeneration could be established.
20 One of the principle methods behind tissue engineering involves growing the relevant cell(s) in vitro into the required three-dimensional (3D) organ or tissue. But cells lack the ability to grow in favoured 3D orientations and thus define the anatomical shape of the tissue. Instead, they randomly migrate to form a two-dimensional (2D) layer of cells. However, 3D tissues are 25 required and this can be achieved by seeding the cells onto porous matrices, known as scaffolds, to which the cells attach and colonise. The scaffold therefore is a very important component for tissue engineering. Several requirements have been identified as crucial for the production of tissue engineering scaffolds: (1) the scaffold should possess interconnecting pores of 2 appropriate scale to favour tissue integration and vascularisation, (2) the scaffold should be made from material with controlled biodegradability or bioresorbability so that tissue will eventually replace the scaffold, (3) the scaffold should have appropriate surface chemistry to favour cellular 5 attachment, differentiation and proliferation, (4) the scaffold should possess adequate mechanical properties to match the intended site of implantation and handling, (5) the scaffold should not induce any adverse response and, (6) the scaffold should be easily fabricated into a variety of shapes and sizes. Bearing these requirements in mind, several materials have been adopted or 10 synthesised and fabricated into scaffolds.
Investigations into synthetic and natural inorganic ceramic materials (e.g. hydroxyapatite and tricalcium phosphate) as candidate scaffold material have been aimed mostly at bone tissue engineering. This is because these ceramics resemble the natural inorganic component of bone and have 15 osteoconductive properties. However, these ceramics are inherently brittle and cannot match the mechanical properties of bone. It should be mentioned that bone is a composite comprising a polymer matrix reinforced with ceramic particles. The polymer is the protein collagen, 30 % dry weight, and hydroxyapatite (HA), 70 % dry weight. Moreover, ceramic scaffolds cannot be 20 expected to be appropriate for the growth of soft tissues (e.g. heart muscle tissue) considering that these tissues possess different cellular receptors and mechanical property requirements. Synthetic polymers are an attractive alternative and versatile in their applications to the growth of most tissues.
Several synthetic polymers have been proposed in the preparation of 25 scaffolds. Aliphatic polyesters such as polyglycolic acid (PGA), polylactic acid (PLLA), their copolymers (e.g. PLGA) and polycaprolactone (PCL) are the most commonly used polymers for tissue engineering scaffold applications. The degradation products of these polymers (glycolic acid and lactic acid) are present in the human body and are removed by natural metabolic pathways.
3
Hydrophilic synthetic materials intended for biomedical applications have been disclosed which have improved properties when compared to conventional materials when it comes to physico-chemical properties.
Examples of such material are the cross-linked polyurethane-based hydrogels 5 as disclosed in e.g. US-A-3 903 232, US-A-3 961 629, US-A-4 550 126 and EP-A-0 335 669. However, these materials are biodurable and not biodegradable or bioresorbable.
The lack of biodegradability makes such materials less suitable for application in vivo. In a recent articles on polymer scaffolds, the fundamental 10 differences between biodegradable polymers and biostable polymers (or non-degradable polymers are discussed (Shoichet, Polymers 2010, 43(2), 581-591).
WO-A-2004/062704 describes a biodegradable absorbent foam that comprises a phase-separated polymer consisting of an amorphous segment and 15 a crystalline segment, wherein the amorphous segment comprises a hydrophilic segment.
Although promising candidates for biodegradable scaffolds useful in tissue engineering have been described in the art, there remains room for improvement. For instance, although polyurethane are promising candidates 20 for scaffolds due to their high level of biocompatibihty, their hydrophobic nature limits cell adhesion and thereby the application in cell seeded constructs. In addition, it would be desirable to provide an activated scaffold, for instance, in order to functionalise the scaffold with desirable compounds, such as suitable growth factors for cells. Preferably, such activation or 25 functionalisation would be achieved homogeneously throughout the scaffold.
Objective of the invention is therefore to provide a biodegradable porous polymer network with a desirable degree of hydrophilicity.
Another objective of the invention is to provide a biodegradable porous hydrophilic polymer network which has good mechanical properties, 30 such as stiffness.
4
Further objective of the invention is to provide a process for making a biodegradable porous polymer network more hydrophihc by generating free hydrophihc groups.
Yet a further objective of the invention is to provide a biodegradable 5 porous polymer network that can be functionahsed with biological molecules.
The inventors surprisingly found that one or more of the above objectives can, at least in part, be met by a biodegradable porous polymer network that comprises specifically defined free functional groups.
Accordingly, in a first aspect the invention is directed to a 10 biodegradable porous polymer network, comprising a phase-separated biodegradable polymer, said polymer comprising an amorphous segment and a crystalline segment, at least said amorphous segment comprising a hydrophihc segment, wherein the scaffold comprises free groups of the following structure
O
II H 1 H 9 Y C N R N R , wherein 15 Y is selected from CH2 or NH, R1 is selected from the groups consisting of an optionally substituted linear or branched Ci-Cis alkyl or alkenyl group, an optionally substituted C3-C8 cycloalkyl group, an optionally substituted aryl group, and an optionally substituted C7-C10 aralkyl group, and 20 R2 is hydrogen, or comprises a biological compound.
The inventors found that such a poisoner network has advantageously has an increased degree of hydrophilicity in comparison with the same polymer network wherein the specifically defined free functional groups are absent. Surprisingly, good mechanical properties of the polymer 25 network can be maintained despite the insertion of the free functional groups, in particular good stiffness.
The free functional groups can be readily introduced by aminolysis. Although aminolysis of non-biodegradable polyurethane is known, it is surprising that this mechanism can be successfully apphed to the essentially 5 different biodegradable (or bioresorbable) polymers of the invention. Moreover, it was found that after modification the functional groups are unexpectedly distributed substantially homogeneous over the entire porous polymer network. Furthermore, non-biodegradable polyurethanes have the 5 disadvantage of being normally based on aromatic isocyanates, which give rise to harmful by-products.
In accordance with the invention, the amorphous segment must comprise a hydrophilic segment. This amorphous segment, also called the amorphous phase, is amorphous when wet (viz. in the wet state) despite the 10 fact that it may comprise a crystalline polyether. This means that, in the dry state, said crystalline polyether may provide the amorphous phase of the polymer with partially crystalline properties.
The phase-separated character of the polymer on which the porous polymer network of the invention is based, provides the material with 15 desirable characteristics. Without wishing to be bound by any theory, the inventors believe that phase-separation of the various soft (amorphous) and hard (crystalline) segments attributes to the specific mechanical properties of the polymer network, such as its resilience. This is advantageous, for instance, for scaffold applications.
20 The presence of a hydrophilic segment or group in the amorphous phase of the polymer from which the polymer network of the invention is comprised further provides the polymer network with desirable characteristics for scaffold applications, such as the capacity of absorbing aqueous liquids and being readily biodegradable.
25 The polymer network of the invention can comprise a relatively large amount of free groups with the structure —Y—C(=0)—NH—R1—NH—R2. Preferably, the biodegradable porous polymer network comprises an amount of 2.5 mmol or less of free groups of structure —Y— C(=0)-NH—R1—NH—R2 per gram of total porous polymer network, preferably 2.0 mmol per gram of total 30 porous polymer network, more preferably 1.0 mmol or less per gram of total 6 porous polymer network, such as 0.5 mmol or less per gram of total porous polymer network, 0.2 mmol or less per gram of total porous polymer network, or 0.1 mmol or less per gram of total porous polymer network. The lower limit of free groups with the structure — Y—C(=0)—NH—R1—NH—R2 is not critical, 5 as long as free groups are present. The amount of free amines can, for instance, be determined via staining with e.g. ninhydrin and absorbance spectroscopy.
In a highly preferred embodiment of the invention, these free groups are present both on the outer surface of the polymer network, as well as within 10 the bulk of the polymer network (i.e. on the inner surface of the porous polymer network). More preferably, the free groups are distributed substantially homogeneous throughout the porous polymer network. As used herein, the term “distributed substantially homogeneous” is meant to be understood that the relative difference in the amount of free groups 15 — Y—C(=0)—NH—R1—NH—R2 at two different locations of 1 mm3 in the porous polymer network is not more than 10 % in relative terms, preferably not more than 5 % in relative terms. The level of homogeneity of the distribution of the free groups can suitably be determined by confocal microscopy, which allows detection in three dimensions.
20 The biodegradable phase-separated polymer comprised in the polymer network of the invention is preferably based on a biodegradable phase-separated polymer of the following formula (I), which is subsequently aminolysed: —[R—Q![—R’—Z1—[R”—Z2—R’—Z3]p—R”—Z4]q—R’—Q2]n— (I), 25 wherein R is selected from one or more aliphatic polyesters, polyetheresters, polyethers, poly anhydrides and/or polycarbonates, and at least one R comprises a hydrophilic segment, R’ and R” are independently C2-C8 alkylene, optionally substituted with C1-C10 alkyl or C1-C10 alkyl groups substituted with protected 7 S, N, P or O moieties and/or comprising S, N, P or O (e.g. ether, ester, carbonate and/or anhydride groups) in the alkylene chain, Z!-Z4 are independently amide (—NH—C(=0)—), urea (—NH—C(=0)-NH—) or urethane (—NH—C(=0)-0-), 5 Q1 and Q2 are independently urea (—NH—C(=0)—NH—), urethane(—NH—C(=0)—O—), amide (—NH—C(=0)—), carbonate (-0-0(=0)-0-), ester (-0(=0)-0-), or anhydride (-0(=0)-0-0(=0)-), n is an integer from 5-500, and p and q are independent 0 or 1, provided that when q is 0, R is a mixture of at least one crystalline polyester, polyetherester 10 or polyanhydride segment and at least one amorphous aliphatic polyester, polyether, polyanhydride and/or polycarbonate segment.
Polymers of general formula (I), and processes for the preparation thereof, are known from WO-A-2004/062704, the content of which is herewith completely incorporated by reference.
15 The 0 containing moieties in the alkylene chain, if present, are preferably hydrophilic groups, in particular ether groups, since such hydrophilic groups can provide a reduced degradation time to the polymer, which may be desirable for the polymer’s use in implants.
The simplest form of such polymer is the case when q = 0. In this 20 case, the polymer may be represented by the following formula (II), -[R-Q!-R’-Q2]n- (II)
The amorphous segment is comprised in the — R— part of the polymer according to formula (I). In case q = 1, the QR—R’—Z1—[R”—Z2—R’—Z3]p—R”—Z4]q—R’—Q2 part of the polymer according to 25 formula (I) represents the crystalline segment. In this particular case the amorphous and crystalline segments are alternating, thus providing the hard segment with a uniform block-length.
R may represent a mixture of two or more different types of aliphatic polyesters, polyetheresters, polyethers, poly anhydrides and/or polycarbonates, 30 which mixture comprises both amorphous and crystalline types, so that both 8 are comprised in a scaffold of the invention. In the case that a mixture of amorphous and crystalline types of R segments are provided in a polymer according to the formula (I), at least one hydrophilic segment is provided in at least one amorphous R segment.
5 Q1 and Q2 may be selected from amide, urea, urethane ester, carbonate or anhydride groups, whereas Z1 through Z4 can be chosen from amide, urea or urethane groups. In the preparing the biodegradable phase-separated polymer used in the polymer network of the invention, one or more of Q1, Q2, Z1, Z2, Z3, and Z4 can be attacked by the diamine via aminolysis 10 to provide free groups of the following structure 0 II H 1 —Y—C—N—R-NH2 wherein Y and R1 have the same meaning as defined in claim 1. In the context of this application, the biodegradable porous polymer network having such free amine groups is considered to be “activated”. The free amine groups can 15 optionally be further reacted with one of more moieties that comprise a biological compound, thereby providing a biodegradable porous polymer network that is functionalised. In the latter case, the biodegradable porous polymer network of the invention will comprise free groups of the following structure
O
II H 1 H 9 20 -Y—C—N—R1—N—R , wherein Y and R1 have the same meaning as defined in claim 1, and wherein R2 comprises a biological compound.
In accordance with the invention, the free groups of the structure
O
II H 1 H 9 —Y—C—N—R1—N—R^ 25 can have an aliphatic R1 moiety, an aliphatic R1 moiety, or an R1 moiety which comprises both aliphatic and aromatic parts. Preferably, R1 is selected from 9 the group consisting of an optionally substituted linear or branched Ci-Cis alkyl group, an optionally substituted C3-C8 cycloalkyl group, and an optionally substituted aryl group (such as an optionally substituted phenyl group), and an optionally substituted C7-C10 aralkyl group. More preferably, R1 is selected 5 from the group consisting of an optionally substituted bnear or branched C1-C18 alkyl group, and an optionally substituted C3-C8 cycloalkyl group.
The group R’ in —Z2—R’—Z3— may be the same or different (or similar) to R’ in —Q1—R’—Z1— or — Z4—R— Q2—.
The hydrophihc segment (which is comprised in R in formulas (I) 10 and (II) above) can suitably be an ether segment, such as a polyether segment derivable from such polyether compounds as polyethylene glycol, polypropylene glycol or polybutylene glycol. Also, a hydrophihc segment may be derived from polypeptide, poly(vinyl alcohol), poly(vinyl pyrrolidone) or poly(hydroxylmethyl methacrylate). A hydrophilic segment is preferably a 15 polyether.
The term “biodegradable” as used in this application is meant to refer to the ability of a polymer to be acted upon biochemically in general by living cells or organisms or part of these systems, including hydrolysis, and to degrade and disintegrate into chemical or biochemical products.
20 The term “bioresorbable” as used in this application is meant to refer to the ability of being completely metabolised by the human or animal body.
The term “polymer network” as used in this application is meant to refer to a plurality of polymeric strands held together by any of a variety of 25 means, such as covalently bonded cross-linking units, long range attractive forces, hydrogen bonds, entanglement of the molecular chains, etc. The polymeric strands can be a single polymer or a blend, and the polymer network may contain other substances within the bulk of the network or on the surface of the network. A porous polymeric network typically provides sufficient 30 structure for a degree of rigidity, and has spaces between the polymeric 10 strands which may be occupied by other components. Preferably, the polymer network of the invention is a network of interconnected pores.
The term “phase-separated polymer” as used in this application is meant to refer to a polymer comprising soft (amorphous) segments, as well as 5 hard (crystalline) segments, the hard segment having a phase transition temperature of at least mammalian body temperatures (which is generally 37 °C for humans) and the phase-separated morphology being manifest when the polymer network prepared from such a polymer is applied in the human or animal body for a sufficient period of time. Also, the polymer placed under 10 temperature conditions comparable to the human or animal body exhibits said phase-separated morphology. A phase-separated polymer is characterised by the presence of at least two immiscible or partly miscible phases with a different morphology at normal environmental conditions. Within one material a rubber phase and a crystalline phase (at a temperature above the glass 15 transition temperature of the amorphous phase and below the melting temperature of the crystalline phase) may be present or a glassy and a crystalline phase (at a temperature below the glass transition temperature of the amorphous phase). Also, at least two amorphous phases can be present at a temperature between the two phase transitions, e.g. one glassy and one 20 rubbery phase. At a temperature above the highest phase transition which is either a melting temperature or a glass transition temperature, the liquid and rubbery or the two rubbery phases, respectively, can form a phase mixed morphology or they can still be immiscible. The presence of immiscible liquid and/or rubbery phases usually results in a polymer with phase-separated 25 morphology without the initial desired mechanical properties at normal environmental conditions.
The term “amorphous” as used in this application is meant to refer to segments present in the polymer of the invention with at least one glass transition temperature below mammalian body temperatures, and may also 30 refer to a combination of an amorphous and crystalline segment which is 11 completely amorphous at mammalian body temperatures. For example, polyethylene glycol (PEG) in a pre-polymer may be crystalline in pure form, but may be amorphous when comprised in the R segment of a polyurethane of the formula (I) or (II). Longer PEG segments may also be partly crystalline 5 when comprised in the R segment of a polyurethane of the formula (I) or (II), but will become amorphous (“dissolves”) when placed in contact with water. Therefore, such longer PEG segments are part of the soft segment of the phase separated polymer of the formulas (1) or (II), whereas the hard segment should remain crystalline in nature to provide sufficient support to a foam in the wet 10 and packed state for, at least, a certain period of time.
The term “crystalline” as used in this application is meant to refer to segments, present in the polymer of the invention, that are crystalline at mammalian body temperatures, i.e. that have a melting temperature above mammalian body temperatures.
15 The term “hydrophilic segment” as used in this application is meant to refer to a segment comprising at least one, preferably at least two, more preferably at least three hydrophilic groups such as can be provided for instance by C—O—C, or ether, linkages. A hydrophilic segment may thus be provided by a polyether segment. A hydrophilic segment may also be provided 20 by polypeptide, poly(vinyl alcohol), poly(vinyl pyrrolidone) or poly(hydroxylmethyl methacrylate). A hydrophilic segment is preferably derived form polyalkylene glycol, such as polyethylene glycol, polypropylene glycol, or polybutylene glycol. The preferred hydrophilic segment is a polyethylene glycol (PEG) segment.
25 The term “segment” as used in this application is meant to refer to a polymeric structure of any length. In the art of polymer technology a long polymeric structure is often referred to as a block, whereas a short polymeric structure is often referred to as a segment. Both these conventional meanings are understood to be comprised in the term “segment” as used herein.
12 A biodegradable porous polymer network according to the invention can comprise a polymer wherein urethane, urea or amide bonds are provided. These bonds constitute part of the crystalline segment of the polymer. Since these hard, crystalline segments are chemically incompatible with amorphous 5 segments, phase separation in the polymer occurs. The hard segments crystallise and form strong hydrogen bonds with other hard segments resulting into physical cross-links.
Furthermore, the biodegradability of the material can suitably be accomplished by the provision of enzymatically cleavable or hydrolysable 10 bonds. For the material to be biodegradable, several types of polymers known to the art may thus be comprised in the polymer. Such biodegradable polymers may include polymers with one or more ester, anhydride and/or carbonate hydrolysable moieties, optionally combined with ether moieties. Such groups are very suitable provided in the R element according to the formula (I) or (II) 15 for a polymer for use in a scaffold of the invention, although the ether or ester moieties may also be comprised in the R’ and/or R” elements of the crystalline segment. In the case that q is zero in polymers of formula (I) or in the case that there are no hydrogen-bond forming groups present in the copolymer, e.g. in polymers other than those of formula (I), i.e. such as in those of the formula 20 (II), phase-separation of crystalline hard segment and amorphous soft segments is provided by incompatible polyether, polyester, polyanhydride and/or polycarbonate groups, at least one phase being crystalline, comprised for example through R in formula (I) or otherwise.
It is believed that the polymers used in the polymer network of the 25 invention can degrade by the hydrolysis and/or enzymatic mechanism of ester, carbonate, anhydride, urethane, urea or amide linkages. The rate of degradation and other properties can be regulated by choosing the content and combination of these moieties in the polymer.
Examples of synthetic biodegradable polymers that can be applied in 30 the manufacturing of the porous polymer network of the invention are those 13 based on polyesters, polyhydroxy acids, polylactones, polyetheresters, polycarbonates, polydioxanones, polyanhydrides, polyurethanes, polyester(ether)urethanes, polyurethane urea, polyamides, polyesteramides, poly-orthoesters, polyaminoacids, polyphosphonates and polyphosphazenes.
5 The polymeric material may also be composed of mixtures of above components either as different building blocks of the copolymer or cross-linked polymer or as a blend of two or more (co)polymers.
For providing the porous polymer network with absorbent characteristics, it has furthermore been found that the polymers used for the 10 preparation of the polymer network of the invention can be improved considerably by combination of the polymer with hydrophilic polymers or groups. This means that the above mentioned polymers are chemically combined with these hydrophilic groups, e.g. by incorporating hydrophilic polymers in the backbone or side-chains of the resulting polymers. Also, a 15 polymer network of the invention may comprise physical blends of biodegradable and hydrophilic polymers. Hydrophilic polymers or groups may be based on polyethers, polypeptides, poly(vinyl alcohol), poly(vinyl pyrrolidone) or poly(hydroxylmethyl methacrylate) (poly-HEMA). The preferred hydrophilic polymer is a polyether, viz. a polymer or segment 20 comprising at least one —C—O—C— group, because these compounds are easy to handle in chemical synthesis reactions. Moreover, these compounds are generally regarded as safe (GRAS). The preferred polyether is polyethylene glycol. The hydrophilic groups are part of the soft segment where they will increase the degradation rate of the ester, carbonate or anhydride groups 25 under the conditions were the scaffold of the invention is to be applied, and may additionally be part of the hard segment.
In particular, the absorption capacity (amount of water uptake and rate thereof) and degradation behaviour can thus be controlled by incorporating during synthesis a suitable quantity of these hydrophilic 30 polymers or groups. It is thus also possible to incorporate hydrophilic groups 14 into the hard segment to increase the solubility and/or rate of degradation of the hard segment and thus shorten the time needed for complete degradation or resorption of the polymer, however, care should be taken that the hard segment provides the phase-separated polymer with sufficient resilience, even 5 when wet.
From the above it is clear that, by proper selection of the soft and hard segments the period of time for biodegradation by enzymes and fluids of the human or animal body can be controlled, as well as the extent to which the material is degraded. Complete biodegradation will result in fragments that 10 are small enough to be metabolised by the body. A polymer network according to the invention may suitably comprise polymeric materials that are not completely bioresorbable, but only biodegradable to an extent that allows clearance, in smaller or larger fragments, from the cavity where they were applied.
15 If the polymer network of the invention is applied in the human or animal body and is left in place without the intention of ever being removed thereof (such as in the form of a scaffold), the degradation products have to be metabohsed by the body. Therefore, polymeric material from which a polymer network of the invention is prepared is preferably chosen such that it is 20 completely bio-absorbable (bioresorbable). Application of such a bio-absorbable scaffold in surgical intervention has the advantage that the material does not necessarily have to be removed after surgery, but that it can be left in place.
The polymer network of the invention has the advantage that it typically disintegrates in a period of time of several days, or at maximum 25 several weeks. This reduces the incidence of complications induced by the removal of haemostats and increases patient’s convenience. According to the invention, a material is provided having superior mechanical properties, including excellent elasticity and support to the surrounding tissue, which is important in stanching the flow of blood and/or keeping the tissue in its 30 position. Yet the material is capable of disintegrating rapidly, followed by 15 clearance from a body cavity were it is applied. This combination of features cannot be arrived at by using conventional biodegradable materials of animal derived origin.
The polymer network of the invention may have a density of 0.01-0.2 5 g/cm3, preferably of 0.02-0.07 g/cm3. Furthermore, a polymer network of the invention may have a porosity in the range of from 85 to 99 %, preferably in the range of from 90 to 99 %, such as in the range of 92 to 98 %, or in the range of from 95 % to 98 %. A polymer network of the invention has sufficient fluid absorption capacity at body temperature.
10 The fluid absorption capacity is mainly determined by the capillary absorption of water into the pores, due to the presence of the hydrophilic nature of the polymer and the pore geometry. The amount of water absorbed in a highly porous polymer network is almost equal for a range of porosities, since the total pore volume of the polymer network is hardly affected. This means 15 that the capacity measured in grams of water per gram polymer is dependent on the density of the polymer network: e.g. doubling of the density from 0.01 g/cm3 to 0.02 g/cm3 will give half the absorption capacity (g/g). Therefore, the absorption capacity is measured as the amount of water (g) absorbed per volume (cm3), which is preferably 0.5-0.99 g/cm3, more preferably 0.75-0.97 20 g/cm3. For example, a hydrophilic polyurethane polymer network with a density of 0.04 g/cm3 and having a porosity of 96.4 % can have an absorption capacity of 0.8 g of water per cm3. This is similar to a capacity of 20 grams of water per gram of polymer material.
A polymer network of the present invention has mechanical 25 properties such as a sufficient resilience or elasticity, which are maintained under “wet” conditions, i.e. when the polymer network is in contact with bodily fluids, including e.g. purulent material. A polymer network of the invention with a porosity in the range of 95-98 % preferably has a Young’s modulus of 10 kPa or more, such as in the range of 10-20 kPa. A polymer network of the 30 invention with a porosity in the range of 88-95 % preferably has a Young’s 16 modulus of 18 kPa or more, such as in the range of 18-40 kPa. A polymer network in the invention with a porosity in the range of 80-88 % preferably has a Young’s modulus of 22 kPa or more, such as in the range of 22-40 kPa.
A polymer network of the invention is hydrophilic, viz. shows a good 5 wettability. A good wettability may be defined as having a water contact angle (for water droplets) that is substantially lower than 80°, preferably lower than 40°, more preferably substantially zero degrees. In an embodiment, the polymer network of the invention has a water contact angle of 75° or less, preferably of 70° or less, such as in the range of from 2° to 70°, or in the range 10 of 2° to 50°.
A phase-separated morphology results in a polymer having at least two phase transitions in one polymer as indicated by two melting temperatures, two glass transition temperatures or one melting point and one glass transition temperature.
15 It was found that the above-mentioned requirements can be suitably obtained when the biodegradable polymer in the polymer network is based on a phase-separated synthetic polymer comprising —C(=0)—O— groups in the backbone of the polymer. Preferably, the polymer is a polyurethane (—NH—C(=0)—0—), polyester (-0(=0)-0-), poly anhydride 20 (-0(=0)-0-0(=0)-) or polycarbonate (-0-0(=0)-0-) based polymer, viz. a polymer wherein a nitrogen atom (polyurethane based), carbon atom (polyester or polyanhydride based) or oxygen atom (polycarbonate) is connected to the C-atom of said -0(=0)-0- groups together with either an aliphatic carbon atom next to the O-atom (polyurethane, polyester and polycarbonate) or a 25 carbonyl group (polyanhydride).
The backbone of the polymer is preferably formed of a copolymer, which comprises two or more different units, at least one selected from the urethane, urea or amide moieties, and at least one selected from the group of ester, anhydride or carbonate moieties combined with an ether moiety.
17 A very suitable copolymer for application as a hydrophilic biodegradable foam is a polyether(ester)urethane.
In preferred embodiment, the polymer networks comprising phase-separated polyesters, poly anhydrides and combinations thereof with 5 polycarbonate and polyether groups may be either random or block copolymers in which a block can contain one or more of the above mentioned moieties. Preferably, block copolymers are used, in particular multi-block segmented copolymers in which both a crystalline and an amorphous phase are present. Physical blends of a phase-separated polymer with another phase-separated or 10 a single-phase amorphous (co)polymer may be used in formation of polymer networks with intermediate properties. By varying the combination of polymers, the properties of the resulting polymer network can be tuned such as rate of degradation, hydrophilic and mechanical properties. This is highly advantages for scaffold applications For example, a scaffold of a blend of a 15 polyester urethane and a co-polyester with a similar composition as the soft segment of the polyurethane gives properties intermediate of those of the two components, due to the compatibihty of the polymers. Furthermore, poly(ether)ester urethanes with different soft segment composition, the soft segments being either compatible or not, and with the same type of hard 20 segment may be mixed and produced into a scaffold with intermediate properties.
High molecular weights are not required to obtain a polymer with good initial mechanical properties. Preferred intrinsic viscosities lie between 0.5 and 4 dl/g, depending on the type of polymer that is used. For instance, for 25 certain polyurethanes, an intrinsic viscosity of 0.6 dl/g can still yield a highly porous polymer network with good mechanical properties. Phase-separated polyurethanes according to formula (I) with molecular weights of the pre-polymer of 2000 g/mol may have an initial elastic modulus varying from 30-120 MPa and a tensile strength of 10-45 MPa. The elongation at break 30 varies from 500-1200 % (measured on polymeric films).
18
Alternatively, synthetic polymers may be used based on polyamides (iviz. polymers containing — NH—C(=0)- units in the backbone) or polyurea (viz. polymers containing — NH—C(=0)-NH— units in the backbone). Combinations of urethane, urea and/or amide bnkages in the above mentioned 5 structures are also possible. A very suitable copolymer for appbcation in a hydrophilic biodegradable foam is a poly ether (ester) urethane.
The phase-separated polymers can be semi-crystalline homopolymers, block copolymers or multi-block segmented copolymers. At least one phase has preferably a transition temperature higher than 37 °C. The 10 segment or block with the highest transition temperature is referred to as the “hard” block, while the segment or block with the lowest transition temperature is referred to as the “soft” block. The hard block may consist of urethane, urea, amide, polyester or poly-anhydride groups, preferably with a phase transition from a crystalline to liquid state, or a combination of these 15 elements. The soft block preferably comprises an amorphous polyester, polyanhydride or polycarbonate with a glass transition temperature of 37 °C or below. Such a temperature makes a scaffold very suitable for use in the human body.
The pliability, compressibility and elasticity of the polymer network 20 can be controlled by selecting the ratio between hard and soft blocks as well as their composition in the polymer. The content and composition of the hard block contributes to the initial strength of the polymer network in the wet and dry condition. Therefore, the content and composition of the hard block must be chosen such that sufficient initial strength of the polymer network in the 25 wet and dry condition is obtained. In order to produce a polymer network of which the structure is maintained after wetting, the hard blocks preferably has a less hydrophilic character than the soft blocks. In order to achieve a faster dissolution of the polymer and rapid loss of materials properties, which is in some cases advantageous, a more hydrophilic hard block may be selected.
19
In accordance with the invention, the amorphous segment can comprise one or more selected from polyesters, polyetheresters, polyethers, poly anhydrides and/or polycarbonates. Preferably, the amorphous segment comprises a polyester derived from lactide (D, L or D/L) and e-caprolactone.
5 More preferably, the amorphous segment comprises a polyester derived from lactide (D, L or D/L) and e-caprolactone, and has a number average molecular weight in the range of from 1000 to 4000 g/mol. The amorphous polyester can comprise about 25 wt.% of lactide, about 25 wt.% of e-caprolactone and about 50 wt.% of polyethylene glycol.
10 The amorphous segment can suitably comprise polyethylene glycol in an content of 1-80 wt.% based on total weight of the amorphous segment, more preferably 5-60 wt.%, even more preferably 20-50 wt.%, such as about 50 wt.%.
The crystalline segment preferably comprises a polyurethane block. 15 Such a polyurethane block can be obtained by reaction of a diisocyanate and a diol. A suitable diisocyanate is for example 1,4-butanediisocyanate. A suitable diol is for example 1,4-butanediol. In an embodiment the crystalline segment is derived from 1,4-butanediisocyanate and 1,4-butanediol building blocks (and optional further building blocks). It was found that the mechanical properties 20 obtained with smaller crystalline segments are inferior to the mechanical properties obtained with larger crystalline segments. Therefore, the crystalline segment preferably comprises three diisocyanate building blocks or more, such as in the range of 3-9 diisocyanate building blocks. The number average molecular weight of a polyurethane crystalline segment can be 300 g/mol or 25 more, such as 400 g/mol or more, or 500 g/mol or more.
The crystalline segment can comprise a polyester block. A suitably polyester block can suitably comprise poly(s-caprolactone), poly(glycolic acid), poly (trimethylene carbonate) or combinations thereof. The number average molecular weight of a polyester crystalline segment can be 1000 g/mol or more, 30 such as 1200 g/mol or more, or 1500 g/mol or more.
20
In formulas (I) and (II) above, R is preferably selected from one or more aliphatic polyesters, polyetheresters, polyethers, poly anhydrides and/or polycarbonates, and at least one R comprises a hydrophilic segment.
R’ and R” are independently C2-C8 alkylene, optionally substituted 5 with C1-C10 alkyl or C1-C10 alkyl groups substituted with protected S, N, P or 0 moieties and/or comprising S, N, P or O in the alkylene chain. When no hydrophilic segment is present in the part of the polymer that is associated with the aliphatic polyether, polyester, polyanhydride and/or polycarbonate, a suitable biodegradable and hydrophilic polymer may be provided by selecting 10 at least one R element to be a polyether. Alternatively, the hydrophilic segment may also be comprised in the R’ or R” element, although this is not preferred. A hydrophihc segment is always present in the soft segment.
The R element may suitably comprise an amorphous polyester, obtained, for instance, by ring opening polymerisation of cychc lactones such as 15 lactide (L, D or L/D), glycolide, s-caprolactone, 5-valerolactone, trimethylene carbonate, tetramethylene carbonate, l,5-dioxepane-2-one or para-dioxanone. These polyester pre-polymers preferably contain hydroxyl end-groups obtained by using 1,4-butanediol or polyethylene glycol as an initiator.
R’ is preferably C2-C8 alkylene, optionally substituted with C1-C10 20 alkyl or C1-C10 alkyl groups substituted with protected S, N, P or O moieties and/or comprising S, N, P or O in the alkylene chain. R’ is preferably derived from a diisocyanate of the formula 0=C=N R’ N=C=0 (formula IV), such as alkane diisocyanate, preferably 1,4-butanediisocyanate (BDI).
R” is preferably C2-C8 alkylene, optionally substituted with C1-C10 25 alkyl or C1-C10 alkyl groups substituted with protected S, N, P or O moieties and/or comprising S, N, P or 0 in the alkylene chain.
Z!-Z4 may be urea, amide or urethane, preferably urethane. In that case, the polymer of formula (I) is a polyurethane.
Preferably, the hard segments have a uniform block length. This 30 means that within one polymer according to formula (I), the values for p and q 21 are constant. A uniform block length also implies very good phase-separation and can be obtained by different chain-extending methods.
In a further aspect, the invention is directed to a process for preparing a biodegradable porous polymer network, comprising 5 - aminolysing a polymer network with a diamine, thereby providing the polymer network with free amine groups, wherein the polymer network comprises a phase-separated biodegradable polymer, said polymer comprising an amorphous segment and a crystalline segment, at least said amorphous segment comprising a hydrophilic segment, wherein said 10 polymer comprises one or more selected from a urethane linkage and an ester linkage, and optionally reacting at least part of the free amine groups with one or more moieties that comprise a biological compound.
The inventors found that desirable biodegradable porous polymer 15 networks can advantageously be prepared in a simple method by aminolysing an existing polymer network using a diamine. The existing polymer network may be in the form of a scaffold or film. It was found that this method can yield a porous polymer network which is activated both on the outer surface, as well as within the bulk of the polymer network. If the optional step of reacting the 20 activated porous polymer network with one or more moieties that comprise a biological compound is performed, the method of the invention can yield a porous polymer network which is functionalised both on the other surface, as well as within the bulk of the polymer network.
In a suitable embodiment, the diamine used for aminolysing the existing 25 polymer network can be represented by the formula H2N—R1—NH2. R1 may be an aliphatic moiety or an aromatic moiety, or it may comprise both aliphatic and aromatic parts. R1 can, for instance, be selected from the groups consisting of an optionally substituted linear or branched Ci-Cis alkyl or alkenyl group, an optionally substituted C3-C8 cycloalkyl group, an optionally substituted aryl 30 group (such as an optionally substituted phenyl group), and an optionally 22 substituted C7-C10 aralkyl group. Preferably, R1 is selected from the group consisting of an optionally substituted linear or branched Ci-Cis alkyl group, and an optionally substituted C3-C8 cycloalkyl group.
Examples of suitable diamine compounds include ethylenediamine, 5 1,2-propanediamine, 1,3-propanediamine, 1,4-butanediamine, 1,5-pentanediamine, 1,6-hexanediamine, 1,8-octanediamine, 1,9-nonane diamine, 1,10-decanediamine, 1,12-dodecanediamine, 1,11-tridecanediamine, 1,13-tridecanediamine, 1,14-tetradecanediamine, 1,16-hexadecanediamine, 1,18-octadecanediamine, 10 2,2-dimethyl-l,3-propanediamine, 2-methyl-1,5-pentanediamine, 2-methyl- 1,8-octanediamine, 2,2,4-trimethylhexamethylenediamine, 2,4,4-trimethylhexamethylenediamine, 5-methyl- 1,9-nonanediamine, 2-butyl-2-ethyl- 1,5-pentanediamine, 3-methylhexamethylenediamine, cyclohexanediamine, l,3-bis(aminomethyl)cyclohexane, isophoronediamine, 15 norbornanedimethylamine, 4,4’-diaminodicyclohexylmethane, 2,2 - (4,4’ - diamino dicyclohexyl)p r op ane, 3,3’-dimethyl-4,4’-diaminodicyclohexyhnethane, l,3-bis(aminomethyl)benzene, m-xylylenediamine, o-phenylenediamine 4,4’-methylene-bis(2-ethyl-6-methylaniline), and combinations thereof.
20 In a preferred embodiment of the process of the invention, the polymer network that is aminolysed comprises a polymer according to general formula (I), —[R—Q1 [—R’—Z[R”—Z2—R’—Z3] p—R”—Z 4] q—R’—Q2] n— (I), wherein 25 R is selected from one or more aliphatic polyesters, polyetheresters, polyethers, poly anhydrides and/or polycarbonates, and at least one R comprises a hydrophilic segment, R’ and R” are independently C2-C8 alkylene, optionally substituted with C1-C10 alkyl or C1-C10 alkyl groups substituted with protected S, N, P or O moieties and/or comprising S, N, P or O (e.g. ether, ester, 30 carbonate and/or anhydride groups) in the alkylene chain, 23 Z1, Z2, Z3, and Z4 are independently amide, urea or urethane, Q1 and Q2 are independently urea, urethane, amide, carbonate, ester or anhydride, n is an integer from 5-500, and p and q are independent 0 or 1, provided that 5 when q is 0, R is a mixture of at least one crystalline polyester, polyetherester or polyanhydride segment and at least one amorphous aliphatic polyester, polyether, polyanhydride and/or polycarbonate segment.
In the process of the invention it is preferred that the free amine groups that are provided in the polymer network by aminolysis with the 10 diamine are comprised in free groups of the following structure
O
II H .
-Y—C—N—R-NH2 y wherein Y is selected from CH2 and NH, and R1 is selected from the groups consisting of an optionally substituted linear or branched Ci-Cis alkyl or alkenyl group, an optionally substituted C3-C8 15 cycloalkyl group, an optionally substituted aryl group (such as an optionally substituted phenyl group), and an optionally substituted C7-C10 aralkyl group.
The extent of aminolysis can vary depending on the desired properties of the resulting porous polymer network. These desired properties can differ depending on the intended application. Suitably, the polymer 20 network is aminolysed to an extent that the product has 2.5 mmol of the free amine groups per gram of aminolysed polymer, preferably 2.0 mmol of the free amine groups per gram of aminolysed polymer, more preferably 1.0 mmol or less per gram of aminolysed polymer, such as 0.5 mmol or less per gram of aminolysed polymer, 0.2 mmol or less per gram of aminolysed polymer, or 0.1 25 mmol or less per gram of aminolysed polymer. The free amino groups are preferably comprised in free groups of the structure as defined above. The extent of aminolysis can be controlled by the amount of diamine used in the aminolysis step of the process of the invention. It is also possible to control the extent of aminolysis by the time period of performing the aminolysis step.
24
It is suitable to perform the aminolysis step in the presence of an alcohol, for instance, by using the alcohol as a solvent for the diamine. The type of alcohol is not typically limiting. Suitable examples of alcohols that may be used include isopropanol, 2-butanol, t-butanol, 2-pentanol, 3-pentanol, 5 cyclobutanol, and cyclopentanol. In a preferred embodiment, the aminolysis step is carried out in the presence of a secondary alcohol, such as in the presence of isopropanol.
The aminolysis step can suitably be performed by immersing the polymer network in a solution of the diamine. Such a solution may have a 10 concentration of diamine, for instance, in the range of 1-25 wt.%. The aminolysis step can advantageously be performed at room temperature, i.e. without additional heating. The time period of the aminolysis step can vary, but typically is in the range of from 5 minutes to 480 minutes, such as in the range of from 10 to 240 minutes, from 15 minutes to 120 minutes, or from 20 15 minutes to 90 minutes.
Suitably, the aminolysed polymer network can be subjected to one or more washing steps, such as with water (preferably demineralised water). The aminolysed polymer network may further be subjected to freeze drying.
In the optional step the activated biodegradable porous polymer 20 network can be functionalised by reacting free amine groups with one or more moieties that comprise a biological compound. The one or more moieties that comprise a biological compound suitably comprise a carboxyl group. Such a carboxyl group can suitably react with a free amine group to form an amide bond. The moiety can itself be the biological compound, or it can contain the 25 biological compound. A wide variety of biological compounds can be used. Some examples of suitable biological compounds include nucleic acids, hpids, proteins and free amino adds, carbohydrates, and connective tissue. Preferred examples include heparin, collagen, fibrin, hyaluronic acid, albumin, elastin, hormones, and growth factors.
25
Heparin is a particularly interesting biological compound, since it has binding sites for growth factors thereby allowing the provision of a scaffold based on a biodegradable porous polymer network according to the invention that comprises growth factors for cells. In addition, heparin can protect growth 5 factors from early degradation and attached growth factors remain bioactive.
The one or more moieties that comprise a biological compound may be reacted with the free amine groups through a suitable coupling agent. Examples of such coupling agents are well-known in the art and, for instance, include iV-hydroxysuccinimide, AT-hydroxysulphosuccinimide and carbodiimide 10 coupling agents (such as l-ethyl-3-(3-dimethylaminopropyl) carbodiimide and N, N’- dicy clohexyl-carb o diimide).
Advantageously, the one or more moieties that comprise a biological compound can be coupled to the polymer network at room temperature. Suitably, the polymer network can be subjected to one or more washing step 15 after having performed this optional coupling step so as to remove unbound moieties. Advantageously, the process of the invention yields a biodegradable porous polymer network wherein one or more biological compounds are coupled to the polymer network via covalent linkage.
In a further aspect, the invention is directed to a biodegradable 20 porous polymer network obtainable by the process of the invention. The biodegradable porous polymer network may be in the form of a scaffold or film.
In yet a further aspect, the invention is directed to the use of a biodegradable porous polymer network as a scaffold for tissue engineering. In particular, the biodegradable porous polymer network of the invention finds 25 use in musculoskeletal tissue engineering.
The invention will now be further explained by means of the following examples, which are not intended to limit the scope of the invention in any way.
30 26
Examples
Scaffolds were obtained from Polyganics BV, the Netherlands) consisting of PDLLA/PCL (50/50) and butanediisocyanate. Porous scaffolds consisting of 5 % 5 polymer and 95 % porosity were produced by solvent leaching. Films of the polymer were also produced.
Aminolysis of scaffolds was performed by immersing samples in 5 % 1,6-hexanediamine (Merck, NJ USA) in isopropanol for 60 minutes at room temperature. After stringent washing with demineralised water samples were 10 freeze dried over night.
From the porous scaffolds the amount of free amines were quantified via 1 M ninhydrin staining and absorbance spectroscopy at 535 nm (n = 5). Subsequently, scaffolds were prepared for cress-finking with heparin. Scaffolds were saturated with 50 mM 2-morpholinoethane sulphonic acid buffer (MES, 15 pH 5.0). The reaction was prepared via standard carbodiimide coupling. A total of 0.25 % heparin sulphate (w/v) (Organon, Oss, the Netherlands) was added to 33 mM l-ethyl-3-dimethyl aminopropyl carbodiimide (EDC) and 6 mM iV-hydroxysuccinimide (NHS) in MES buffer. 1 ml of reaction mix (EDC/NHS/heparin in MES) was added per 8 mg of scaffold.
20 After 4 hours of incubation at room temperature, scaffolds were washed: 2 x 60 minutes with 0.1 M Na2HPÜ4, 2 x 60 minutes with 1 M NaCl, 2 x 60 minutes with 2 M NaCl, and 6 x 60 minutes with demineralised water. Finally, samples were freeze dried overnight. Native, aminolysed and heparin loaded scaffolds were compared with the following techniques.
25
Immunofluorescent staining: Cryosections of 5 |im were blocked with 1 % BSA/PBS and subsequently incubated with the following antibodies: HS4C3, P5D4, and GtaMIgALEXA488. Sections were analysed with fluorescent microscopy.
27
Immunofluorescence staining showed heparin binding to the activated scaffold only (see + + group in figure 1). Without diamine activation (- +) no heparin was detected (figure 1). These results were similar in both porous scaffolds and films. Furthermore, heparin staining was visible homogeneous throughout the 5 complete porous scaffold.
Hydrophilicity test: Polymer films were coated with heparin as described above. After coating the sessile droplet method was used to calculate the hydrophilicity of the surface. A water droplet was placed on the polymer film 10 and a icture was made. Contact angle was determined by the angle between the polymer film and the droplet (n = 5).
Aminolysed polyurethane films, and aminolysed with heparin coupling showed a significant decreased water contact angle compared to native scaffolds (figure 2).
15
Mechanical analyse: Porous scaffolds, 8 mm diameter and 5 mm in height, with and without diamine activation and heparin coating were analysed under physiological conditions (PBS, 37 °C). Mechanical properties were analysed with a BOSE ElectroForce™ BioDynamic™ with orthopaedic chamber, 20 equipped with a 22N load-cell. Young’s moduli were determined over 50 % compression at 1 mm/min (n = 6).
After 50 % compression, aminolysed polyurethane scaffolds shows a significant decrease in Young’s modulus of about 50 % compared to native scaffolds. Heparin coupling had no further effect on the mechanical stiffness (figure 3).
25
The surface of the polyurethane scaffold was successfully aminolysed and coupled with heparin. The heparin coating was present throughout the complete scaffold (both inner and outer surface). Coating of the polyurethane with heparin results in an increased hydrophilic surface. The surface 30 activation results in a significant reduction in Young’s modulus.
Claims (20)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL2008038A NL2008038C2 (en) | 2011-12-23 | 2011-12-23 | Activated or biologically functionalised polymer network. |
PCT/NL2012/050911 WO2013095138A1 (en) | 2011-12-23 | 2012-12-21 | Activated or biologically functionalised polymer network |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL2008038A NL2008038C2 (en) | 2011-12-23 | 2011-12-23 | Activated or biologically functionalised polymer network. |
NL2008038 | 2011-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL2008038C2 true NL2008038C2 (en) | 2013-06-26 |
Family
ID=47633523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL2008038A NL2008038C2 (en) | 2011-12-23 | 2011-12-23 | Activated or biologically functionalised polymer network. |
Country Status (2)
Country | Link |
---|---|
NL (1) | NL2008038C2 (en) |
WO (1) | WO2013095138A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016077551A1 (en) * | 2014-11-14 | 2016-05-19 | The University Of Florida Research Foundation, Inc. | Biomimetic pore structures and methods of making biomimetic pore structures |
NL2016527B1 (en) * | 2016-03-31 | 2017-11-02 | Polyganics Ip B V | Tissue-adhesive biomedical materials. |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004062704A1 (en) * | 2003-01-09 | 2004-07-29 | Polyganics B.V. | Biomedical foams |
US20070190108A1 (en) * | 2004-05-17 | 2007-08-16 | Arindam Datta | High performance reticulated elastomeric matrix preparation, properties, reinforcement, and use in surgical devices, tissue augmentation and/or tissue repair |
WO2008008266A2 (en) * | 2006-07-07 | 2008-01-17 | University Of Pittsburgh- Of The Commonwealth System Of Higher Education | Biohybrid elastomeric scaffolds and methods of use thereof |
US20100129422A1 (en) * | 2008-11-26 | 2010-05-27 | Korea Institute Of Science And Technology | Porous biodegradable polymer scaffolds for in situ tissue regeneration and method for the preparation thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3961629A (en) | 1968-06-11 | 1976-06-08 | American Cyanamid Company | Using hydrophilic polyurethane laparotomy sponges |
US3903232A (en) | 1973-10-09 | 1975-09-02 | Grace W R & Co | Dental and biomedical foams and method |
US4550126A (en) | 1985-01-25 | 1985-10-29 | Hydromer, Inc. | Hydrophilic, flexible, open cell polyurethane-poly(N-vinyl lactam) interpolymer foam and dental and biomedical products fabricated therefrom |
US5064653A (en) | 1988-03-29 | 1991-11-12 | Ferris Mfg. Co. | Hydrophilic foam compositions |
-
2011
- 2011-12-23 NL NL2008038A patent/NL2008038C2/en not_active IP Right Cessation
-
2012
- 2012-12-21 WO PCT/NL2012/050911 patent/WO2013095138A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004062704A1 (en) * | 2003-01-09 | 2004-07-29 | Polyganics B.V. | Biomedical foams |
US20070190108A1 (en) * | 2004-05-17 | 2007-08-16 | Arindam Datta | High performance reticulated elastomeric matrix preparation, properties, reinforcement, and use in surgical devices, tissue augmentation and/or tissue repair |
WO2008008266A2 (en) * | 2006-07-07 | 2008-01-17 | University Of Pittsburgh- Of The Commonwealth System Of Higher Education | Biohybrid elastomeric scaffolds and methods of use thereof |
US20100129422A1 (en) * | 2008-11-26 | 2010-05-27 | Korea Institute Of Science And Technology | Porous biodegradable polymer scaffolds for in situ tissue regeneration and method for the preparation thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2013095138A1 (en) | 2013-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kutikov et al. | Biodegradable PEG-based amphiphilic block copolymers for tissue engineering applications | |
Gunatillake et al. | Recent developments in biodegradable synthetic polymers | |
US9061089B2 (en) | Biocompatible, biodegradable polyurethane materials with controlled hydrophobic to hydrophilic ratio | |
Guelcher et al. | Synthesis, in vitro degradation, and mechanical properties of two-component poly (ester urethane) urea scaffolds: effects of water and polyol composition | |
Sartori et al. | Biomimetic polyurethanes in nano and regenerative medicine | |
Jia et al. | Degradable biomedical elastomers: paving the future of tissue repair and regenerative medicine | |
JP5496457B2 (en) | Biodegradable polyurethane and polyurethaneurea | |
ES2281147T3 (en) | COMPOSITIONS OF POLYHYDROXIALCANOATE WITH CONTROLLED DEGRADATION RATES. | |
US20130295081A1 (en) | Polyurethane Composite for Wound Healing and Methods Thereof | |
Singh et al. | Recent advancements in polyurethane-based tissue engineering | |
Yadav et al. | Emulsion templated scaffolds of poly (ε-caprolactone)–a review | |
WO2012097381A1 (en) | At least partially resorbable reticulated elastomeric matrix elements and methods of making same | |
WO2011075183A1 (en) | Injectable/in situ forming tissue polyurethane composites and methods thereof | |
NL2002931C2 (en) | HEMOSTATIC FOAMS. | |
Gunatillake et al. | Biodegradable polyurethanes: Design, synthesis, properties and potential applications | |
Reddy et al. | A comparative review of natural and synthetic biopolymer composite scaffolds. Polymers 2021, 13, 1105 | |
Damodaran et al. | Biomedical polymers: Synthesis and processing | |
Chiono et al. | Synthetic biodegradable medical polyurethanes | |
NL2008038C2 (en) | Activated or biologically functionalised polymer network. | |
Rajan et al. | Polyurethane nanostructures for drug delivery applications | |
Lee et al. | Cell-interactive polymers for tissue engineering | |
Kaur et al. | Polymers as bioactive materials II: synthetic/biodegradable polymers and composites | |
Dempsey et al. | Resorbable polyurethanes | |
JP2019068761A (en) | Cell culture support and cell culture plate | |
Pergal et al. | Synthesis and structure-property relationships of biodegradable polyurethanes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD | Change of ownership |
Owner name: POLYGANICS IP B.V.; NL Free format text: DETAILS ASSIGNMENT: CHANGE OF OWNER(S), ASSIGNMENT; FORMER OWNER NAME: POLYGANICS B.V. Effective date: 20181210 |
|
MM | Lapsed because of non-payment of the annual fee |
Effective date: 20210101 |